Literature DB >> 8287914

Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory.

D K Von Lubitz1, I A Paul, R T Bartus, K A Jacobson.   

Abstract

Spatial memory acquisition in Morris water maze was tested in C57BL/6 mice. Animals were injected once daily with different doses of either N6-cyclopentyladenosine (CPA) or 8-cyclopentyl-1,3-dipropylxanthine (CPX). Drugs were administered for 9 days either concurrently with water maze testing (drugs injected 1 h after each trial), or prior to the entire block of trials. In the latter case, 1 day without injections preceded water maze experiments. Chronic administration of CPA resulted in a significant, dose-dependent reduction of target latencies, rapid development of spatial preference, and the absence of animals unable to perform the task. CPX treated animals did not show significant performance changes, and failed to develop spatial preference. Locomotor disturbances were not the cause of the observed effects. Our results indicate that chronic treatment with agents acting at adenosine A1 receptors results in behavioral effects that are significantly different from those observed following their acute administration. Therefore, particular caution is required in development of adenosine-based strategies targeted at neurodegenerative or cognitive disorders in which chronic treatment is advocated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287914      PMCID: PMC5470544          DOI: 10.1016/0014-2999(93)90522-j

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  34 in total

1.  Spatial learning impairment in a murine model of AIDS.

Authors:  Y Sei; P K Arora; P Skolnick; I A Paul
Journal:  FASEB J       Date:  1992-08       Impact factor: 5.191

2.  Caffeine-induced behavioral stimulation is dose-dependent and associated with A1 adenosine receptor occupancy.

Authors:  G B Kaplan; D J Greenblatt; M A Kent; M M Cotreau; G Arcelin; R I Shader
Journal:  Neuropsychopharmacology       Date:  1992-05       Impact factor: 7.853

3.  Analysis and quantitative evaluation of the depressive effect of adenosine on evoked potentials in hippocampal slices.

Authors:  P Schubert; U Mitzdorf
Journal:  Brain Res       Date:  1979-08-17       Impact factor: 3.252

4.  Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor.

Authors:  A Wauquier; H Van Belle; W A Van den Broeck; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  N6-cyclopentyladenosine impairs passive avoidance retention by selective action at A1 receptors.

Authors:  H J Normile; R A Barraco
Journal:  Brain Res Bull       Date:  1991-07       Impact factor: 4.077

6.  Adenosine modulation of amygdala kindling.

Authors:  M Dragunow; G V Goddard
Journal:  Exp Neurol       Date:  1984-06       Impact factor: 5.330

7.  A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells.

Authors:  O Eidelman; C Guay-Broder; P J van Galen; K A Jacobson; C Fox; R J Turner; Z I Cabantchik; H B Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

8.  Behavioral and electroencephalographic effects of the adenosine1 agonist, L-PIA.

Authors:  J V Martin; K F Berman; P Skolnick; W B Mendelson
Journal:  Pharmacol Biochem Behav       Date:  1989-11       Impact factor: 3.533

9.  Transient and selective blockade of adenosine A1-receptors by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) causes sustained epileptiform activity in hippocampal CA3 neurons of guinea pigs.

Authors:  C Alzheimer; B Sutor; G ten Bruggencate
Journal:  Neurosci Lett       Date:  1989-04-24       Impact factor: 3.046

10.  Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding.

Authors:  J Baumgold; O Nikodijevic; K A Jacobson
Journal:  Biochem Pharmacol       Date:  1992-02-18       Impact factor: 5.858

View more
  18 in total

1.  Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.

Authors:  Vasco C Sousa; Natália Assaife-Lopes; Joaquim A Ribeiro; Judith A Pratt; Ros R Brett; Ana M Sebastião
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

Review 2.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

3.  A3-adenosine receptors: design of selective ligands and therapeutic prospects.

Authors:  Kenneth A Jacobson; Hea O Kim; Suhaib M Siddiqi; Mark E Olah; Gary L Stiles; Dag K J E von Lubitz
Journal:  Drugs Future       Date:  1995-07       Impact factor: 0.148

4.  Intra-hippocampal D-cycloserine rescues decreased social memory, spatial learning reversal, and synaptophysin levels in aged rats.

Authors:  Marta Portero-Tresserra; Margarita Martí-Nicolovius; Mireia Tarrés-Gatius; Ana Candalija; Gemma Guillazo-Blanch; Anna Vale-Martínez
Journal:  Psychopharmacology (Berl)       Date:  2018-02-28       Impact factor: 4.530

5.  Chronic treatment with DCPCX, an adenosine A(1) antagonist, worsens long-term memory.

Authors:  Craig Vollert; Gloria S Forkuo; Richard A Bond; Jason L Eriksen
Journal:  Neurosci Lett       Date:  2013-06-06       Impact factor: 3.046

6.  Mice lacking the adenosine A1 receptor have normal spatial learning and plasticity in the CA1 region of the hippocampus, but they habituate more slowly.

Authors:  Lydia Giménez-Llort; Susan A Masino; Lihong Diao; Alberto Fernández-Teruel; Adolf Tobeña; Linda Halldner; Bertil B Fredholm
Journal:  Synapse       Date:  2005-07       Impact factor: 2.562

7.  Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics.

Authors:  T Skarsfeldt
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

8.  Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia.

Authors:  D K Von Lubitz; R C Lin; N Melman; X D Ji; M F Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-04-21       Impact factor: 4.432

9.  A role for central A3-adenosine receptors. Mediation of behavioral depressant effects.

Authors:  K A Jacobson; O Nikodijević; D Shi; C Gallo-Rodriguez; M E Olah; G L Stiles; J W Daly
Journal:  FEBS Lett       Date:  1993-12-20       Impact factor: 4.124

10.  Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist.

Authors:  D K Von Lubitz; M Beenhakker; R C Lin; M F Carter; I A Paul; N Bischofberger; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1996-04-29       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.